Idexx Laboratories
IDXX
670 hedge funds and large institutions have $14.3B invested in Idexx Laboratories in 2018 Q4 according to their latest regulatory filings, with 85 funds opening new positions, 226 increasing their positions, 246 reducing their positions, and 108 closing their positions.
1.52% more ownership
Funds ownership: 86.63% → 88.15% (+1.5%)
8% less repeat investments, than reductions
Existing positions increased: 226 | Existing positions reduced: 246
4% less funds holding
Funds holding: 697 → 670 (-27)
17% less call options, than puts
Call options by funds: $35M | Put options by funds: $42.4M
21% less first-time investments, than exits
New positions opened: 85 | Existing positions closed: 108
23% less capital invested
Capital invested by funds: $18.7B → $14.3B (-$4.38B)
26% less funds holding in top 10
Funds holding in top 10: 23 → 17 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$132M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$95.5M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$69.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$62.9M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$59.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$97.4M |
| 2 |
Bank of New York Mellon
New York
|
-$78.9M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$54.4M |
| 4 |
Renaissance Technologies
New York
|
-$53.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$46.1M |
IDXX Hedge Fund Activity: Q4 2018 in Review
670 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2018, worth a combined $14.3B — down 23% from $18.7B a quarter earlier.
Sellers outnumbered buyers: 108 funds closed out of IDXX and 85 opened new positions — a net loss of 23 holders — while 246 trimmed existing stakes and 226 added.
The largest buyer was Janus Henderson Group, adding an estimated $132M. The largest seller was Arrowstreet Capital, cutting an estimated $97.4M.
- 670 institutional investors held Idexx Laboratories (IDXX) as of Q4 2018, down from 697 in Q3 2018.
- Funds reported $14.3B of Idexx Laboratories stock for Q4 2018, down 23% quarter-over-quarter.
- 85 funds opened new Idexx Laboratories positions in Q4 2018 and 108 closed out, a net change of -23 holders.
- The largest Idexx Laboratories buyer in Q4 2018 was Janus Henderson Group, an estimated $132M added.
- The largest Idexx Laboratories seller in Q4 2018 was Arrowstreet Capital, an estimated $97.4M sold.
Based on aggregated 13F filings for Q4 2018.